Fundraising Fox

Design Therapeutics

NASDAQ: DSGN

Solana Beach, US · Founded 2017 · 2 known investors

Biotech

Founders & leadership

PS
Pratik Shah, Ph.D.Named on SEC filing
SJ
Sean Jeffries, Ph.D.Named on SEC filing
RL
Rodney Lappe, Ph.D.Named on SEC filing
SG
Simeon George, M.D.Named on SEC filing
AZ
Aseem Z. Ansari, Ph.D.Named on SEC filing
SX
Stella Xu, Ph.D.Named on SEC filing

Investors · 2

RA CapitalBoston
SR One Capital ManagementRedwood City

Reported raises · per SEC filings

Form D private placements

$170.5M disclosed across 2 rounds · 2020–2021

▶$125MraisedFeb 2021 · 26 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Pratik Shah, Ph.D.Executive Officer, Director
  • Joao Siffert, M.D.Executive Officer, Director
  • Rodney Lappe, Ph.D.Director
  • Simeon George, M.D.Director
  • Stella Xu, Ph.D.Director
  • Sean Jeffries, Ph.D.Executive Officer
  • John SchmidDirector
  • Arsani William, M.D.Director
Offering amount
$125M
Amount sold
$125M
First sale
Jan 2021
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$45.5MraisedJun 2020 · 6 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Pratik Shah, Ph.D.Executive Officer, Director
  • Sean Jeffries, Ph.D.Executive Officer
  • Rodney Lappe, Ph.D.Director
  • Simeon George, M.D.Director
  • Aseem Z. Ansari, Ph.D.Director
  • Stella Xu, Ph.D.Director
Offering amount
$45.5M
Amount sold
$45.5M
First sale
Feb 2020
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

BlackRock Inc. Takes Position in Design Therapeutics, Inc. $DSGN - Defense Worlddefenseworld.net · Sep 2026Design Therapeutics Provides RESTORE-FA Clinical Development Update and Reports Second Quarter 2026 Financial Results - BioSpacebiospace.com · Aug 2026Design Therapeutics Strategy and Business Modelumbrex.com · Jun 2026RBC Capital raises Design Therapeutics price target on trial data By Investing.comng.investing.com · May 2026Design Therapeutics Raises $45M in Series A Funding - FinSMEsfinsmes.com · Mar 2020DSGN Stock | Design Therapeutics Price, Quote, News & Analysis - TipRanks.comtipranks.com

Frequently asked questions

Who are Design Therapeutics's investors?
Design Therapeutics's investors include RA Capital, SR One Capital Management.
How much funding has Design Therapeutics raised?
Design Therapeutics has disclosed $170.5M raised across 2 rounds.
Where is Design Therapeutics headquartered?
Design Therapeutics is headquartered in Solana Beach, US.